Key facts
- AlensiaXR’s last known valuation is $20.0M (Jan 2026).
- It has raised $5.3M; the latest was Early Stage VC ($2.1M) in Jan 2026.
- Notable investors include Jumpstart Ventures, JobsOhio Ventures, University Hospitals Ventures, Case Western Reserve University, Sopris Venture Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for AlensiaXR
- ·The full record, as it builds
Funding rounds
No funding rounds for AlensiaXR are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About AlensiaXR
Developer of a learning platform intended to transform the way students learn human anatomy. The company's platform uses advanced mixed-reality technology to illuminate the human body in three dimensions, which helps students to learn fast, retain vital information and transcend the classroom, enabling students to easily learn anatomical content and universities can reduce the expensive, time-consuming tasks of obtaining and maintaining cadavers.
- Sector
- Information Technology
- HQ
- Aurora, OH, United States
- Founded
- 2024
- Employees
- 20
- Website
- alensiaxr.com/
- Ownership
- Privately Held (backing)
AlensiaXR doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in AlensiaXR shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on AlensiaXR in its N-PORT filings yet. We sweep new filings monthly.